Emerging Therapy Solutions & Clarify Health Have Partnered for Improved Predictive Analytics and Data Insights for Health Plans and Providers

Relationship Will Enable ETS to Provide Access to Richer Data for Payers and Plans to Help Them Make Informed Decisions on Pricing Risk for High-Cost, Complex Therapies

April 21, 2023 –Bloomington, MN – Emerging Therapy Solutions^® (ETS), an industry leader in providing cutting-edge services to help payers and other risk-bearing entities prepare for the accelerating growth in cell and gene therapies and other high-cost, complex treatments, today announced a strategic partnership with Clarify Health, a leading healthcare analytics and value-based payments platform company – to help payers and providers better manage the high costs associated with treatments for rare genetic diseases.

“ETS’ partnership with Clarify further enhances our ability to inform the market about what to expect as utilization of these novel, life-saving therapies continues to rise,” said David McLean, Chief Executive Officer of ETS. “We are excited to continue adding quality, cost, and access insights to our market-leading suite of analytics products. Our analytics and financial forecasting products continue to provide the market with the ability to identify, anticipate, and measure performance in the rapidly evolving cell and gene therapy market.”

Clarify’s insights provide an independent source of information on patient journeys, drawing upon over three hundred million lives across commercial and public payer sectors. ETS’ use of these insights will benefit payers, providers, and patients, allowing ETS to provide comprehensive experience-based products, further refining our exposure-based products, tracking adoption rates and uptake, and measuring outcomes. Insights are expected to greatly enhance predictive capability for both patient identification and macroeconomic forecasting, to provide more patients with access to life-saving therapies, guiding care to expert providers, and to take cost out of the system.

According to Tim Michaels, ETS Senior Vice President – Insurance Risk Services, “Our partnership with Clarify demonstrates ETS’s continued commitment to being the preeminent firm for helping payers in managing the risks associated with high-cost therapies for rare and complex conditions. Through this relationship, our data and analytics assets represent a nearly complete claims view of the US market and will provide our clients a detailed, comprehensive view of market activity over multiple years.”

About Emerging Therapy Solutions
Emerging Therapy Solutions (ETS) helps reinsurance and stop-loss payers, health plans and self-funded employers manage the risks associated with high-cost therapies for rare and complex conditions. We offer a comprehensive suite of services for solid organ and bone marrow transplants, cell and gene therapies, and other highly specialized therapies.

About Clarify Health
Clarify Health is an enterprise analytics and value-based payments platform company that empowers payers, providers, and life sciences companies to deliver better care, therapies, and outcomes with actionable patient journey insights. Clarify’s cloud-based business applications are built on the Clarify Atlas Platform, which maps 300M+ patient journeys to deliver 18B+ AI-powered predictions and surface insights with speed and precision. Clarify’s products illuminate actionable opportunities to drive growth, optimize networks, improve care delivery, manage population health, maximize value-based care performance, and bring therapies to market. With Clarify, healthcare organizations can leapfrog from point-solution and manual analytics to self-service, rapid generation of enterprise insights that light the path to better care and outcomes.

# # #